News


All News

As a rule, in order to maintain cosmetic effects from various noninvasive rejuvenation devices currently available on the market, treatments must be repeated. How often these treatments must be repeated is the central issue, and leading noninvasive devices continue to vie for the top spot.

The advent of fractional resurfacing technologies has raised many controversial questions, an expert says. However, he says what's beyond dispute is that even the most effective resurfacing device works best in the context of combination treatments.

Considering genetics, as well as clinical presentation, will aid in managing challenging cases of skin cancer. It is also incumbent upon clinicians to conduct a comprehensive review of the medical literature to assess the risks associated with metastases of some lesions, such as proliferating trichelemal tumors, according to an expert who treats mainly skin cancer cases.

It's imperative for woundcare specialists to ensure that urine and stool are kept away from the skin. To ensure this, clinicians need to use appropriate barriers. It's also paramount that the barriers be properly removed. If they are not, that can trigger skin damage. Whatever the choice of products used to protect the skin, following structured protocols will keep the integrity of the skin intact.

Clinicians should aim to improve the symptom management of malignant wounds, particularly in cases of advanced cancer. One proposed tool to do this is the Toronto Symptom Assessment System for Wounds (TSAS-W). In a pilot study, TSAS-W demonstrated that malignant wounds were the most symptomatic class of wounds.

Economists debate whether the United States has reached a full-fledged recession or is simply teetering on the brink, waiting for some sign it will either topple or be pulled back. Meanwhile, as the debate rages, people are dealing with the effects of soaring energy costs, rising unemployment and inflation.

It is with great pleasure that we announce the addition of Elaine Siegfried, M.D., to the Dermatology Times Editorial Advisory Board. Dr. Siegfried will join Ronald Wheeland, M.D.; Norman Levine, M.D.; and Zoe D. Draelos, M.D., in helping to guide the editorial content of the magazine's print edition, as well as its Web site at www.dermatologytimes.com.

New York - The Skin Cancer Foundation is now accepting applications for its annual awards to support pilot research projects related to skin cancer. The foundation will award four $10,000 grants for basic research and clinical studies that address improved methods of prevention, detection and treatment of skin cancer.